Emerson Strengthens Leadership in Life Sciences Industry with Acquisition of Fluxa

ST. LOUIS--(BUSINESS WIRE)--Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on Emerson’s leading software and solutions portfolio and life sciences...

Click to view original post